Abbott Laboratories · Stock-Based Compensation

Latest reported$718.00Mperiod endingJun 30, 2026

ABT Stock-Based Comp ($0.00 → $718.00M)

Annual stock-based compensation

High-resolution chart · PNG

ABT stock-based compensation history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Abbott Laboratories Stock-Based Compensation — Annual fiscal periods (USD)
Period ending	Stock-Based Compensation (USD)
Dec 31, 2025	664,000,000
Dec 31, 2024	673,000,000
Dec 31, 2023	644,000,000
Dec 31, 2022	685,000,000
Dec 31, 2021	640,000,000
Dec 31, 2020	546,000,000
Dec 31, 2019	519,000,000
Dec 31, 2018	477,000,000
Dec 31, 2017	406,000,000
Dec 31, 2016	310,000,000
Dec 31, 2015	292,000,000
Dec 31, 2014	246,000,000
Dec 31, 2013	262,000,000
Dec 31, 2012	433,000,000
Dec 31, 2011	383,000,000
Dec 31, 2010	387,183,000
Dec 31, 2009	366,357,000
Dec 31, 2008	347,015,000
Dec 31, 2007	46,330,000
Dec 31, 2006	136,474,000
Dec 31, 2005	9,745,000
Dec 31, 2004	-10,220,000
Dec 31, 2003	-7,657,000
Dec 31, 2002	11,719,000
Dec 31, 2001	0
Dec 31, 2000	0
Dec 31, 1999	0
Dec 31, 1998	0
Dec 31, 1997	0
Dec 31, 1996	0
Dec 31, 1995	0
Dec 31, 1994	0
Dec 31, 1993	0
Dec 31, 1992	0
Dec 31, 1991	0
Dec 31, 1990	0
Dec 31, 1989	0